About: Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City
Creator	Whittier, Susan Satlin, Michael Sobieszczyk, Magdalena Westblade, Lars Green, Daniel Aaron, Justin Choi, Justin Connelly, Charles Dietz, Donald Greendyke, William Liu, Dakai Russell, Sarah Sepulveda, Jorge Zucker, Jason
Source	Medline; PMC
abstract	A surge of patients with coronavirus disease 2019 (COVID-19) presenting to New York City hospitals in March 2020 led to a sharp increase in blood culture utilization, which overwhelmed the capacity of automated blood culture instruments. We sought to evaluate the utilization and diagnostic yield of blood cultures during the COVID-19 pandemic to determine prevalence and common etiologies of bacteremia and to inform a diagnostic approach to relieve blood culture overutilization. We performed a retrospective cohort analysis of 88,201 blood cultures from 28,011 patients at a multicenter network of hospitals within New York City to evaluate order volume, positivity rate, time to positivity, and etiologies of positive cultures in COVID-19. Ordering volume increased by 34.8% in the second half of March 2020 compared to the level in the first half of the month. The rate of bacteremia was significantly lower among COVID-19 patients (3.8%) than among COVID-19-negative patients (8.0%) and those not tested (7.1%) (P < 0.001). COVID-19 patients had a high proportion of organisms reflective of commensal skin microbiota, which, when excluded, reduced the bacteremia rate to 1.6%. More than 98% of all positive cultures were detected within 4 days of incubation. Bloodstream infections are very rare for COVID-19 patients, which supports the judicious use of blood cultures in the absence of compelling evidence for bacterial coinfection. Clear communication with ordering providers is necessary to prevent overutilization of blood cultures during patient surges, and laboratories should consider shortening the incubation period from 5 days to 4 days, if necessary, to free additional capacity.
has issue date	2020-07-23(xsd:dateTime)
bibo:doi	10.1128/jcm.00875-20
bibo:pmid	32404482
has license	no-cc
sha1sum (hex)	0e8cfa5c3267e1c80ccd6897fc117f0147c007bf
schema:url	https://doi.org/10.1128/jcm.00875-20
resource representing a document's title	Bacteremia and Blood Culture Utilization during COVID-19 Surge in New York City
has PubMed Central identifier	PMC7383550
has PubMed identifier	32404482
schema:publication	J Clin Microbiol
resource representing a document's body	covid:0e8cfa5c3267e1c80ccd6897fc117f0147c007bf#body_text
is schema:about of	named entity 'volume' named entity 'bacteremia' named entity 'automated' named entity 'COVID-19' named entity 'COVID-19' named entity 'positive' named entity 'patients' named entity 'blood culture' named entity 'skin microbiota' named entity 'multicenter' named entity 'Bloodstream' named entity 'New York City' named entity 'FREE' named entity 'EVIDENCE FOR' named entity 'NECESSARY' named entity 'TO INFORM' named entity 'COVID-19 PANDEMIC' named entity 'ORDER' named entity 'DIAGNOSTIC' named entity 'ABSENCE OF' named entity 'VERY RARE' named entity 'EXCLUDED' named entity 'days' named entity 'compared' named entity 'high' named entity 'overutilization' named entity 'incubation' named entity 'positivity' named entity 'blood culture' named entity 'performed' named entity 'shortening' named entity 'order' named entity 'New York City' named entity 'prevent' named entity 'coinfection' named entity 'COVID-19' named entity 'bacteremia' named entity 'blood culture' named entity 'retrospective cohort' named entity 'etiologies' named entity 'COVID' named entity 'COVID' named entity 'New York City' named entity 'Bacteremia' named entity 'pandemic' named entity 'RT-PCR' named entity 'COVID-19' named entity 'ANOVA' named entity 'blood cultures' named entity 'Columbia University Irving Medical Center' named entity 'RT-PCR' named entity 'blood cultures' named entity 'SARS-CoV-2' named entity 'Becton, Dickinson' named entity 'blood cultures' named entity 'blood cultures' named entity 'blood cultures' named entity 'respiratory syncytial virus' named entity 'Cutibacterium acnes' named entity 'blood cultures' named entity 'incubation period' named entity 'blood cultures' named entity 'March 2020' named entity 'blood cultures' named entity 'blood cultures' named entity 'New York City' named entity 'blood cultures' named entity 'ggplot2'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software